Physician profile
William Bret Smith
NPI 1568673911
$7,687,401.23
in general payments reported to CMS, 2019-2025
17 companies · $950K in 2025
The $950K reported for 2025 was more than what 99% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $396K · 2020: $636K · 2021: $1.0M · 2022: $1.5M · 2023: $1.6M · 2024: $1.5M · 2025: $950K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $3.5M · Consulting Fee: $501K · Travel and Lodging: $60K · Food and Beverage: $6,490 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $11.87.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $3,521,691.83 |
| Consulting Fee | $501,125.00 |
| Travel and Lodging | $60,356.86 |
| Food and Beverage | $6,490.46 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $11.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $7,574,765.71 | 2019-2025 | |
| Extremity Medical | $94,137.83 | 2019-2025 | Axis, Omni |
| Orthofix Medical, INC. | $11,715.67 | 2019-2022 | |
| Gemini Mountain Medical, LLC | $2,157.76 | 2020-2021 | |
| Arthrex, INC. | $1,601.02 | 2020-2025 | |
| Smith+Nephew, INC. | $1,115.44 | 2019-2022 | |
| Flower Orthopedics Coporation | $989.31 | 2019-2022 | |
| Vilex LLC | $208.41 | 2024 | |
| Stryker Corporation | $166.67 | 2024 | 7 X 23mm Citrelock Implant, Invision, Ortholoc 2 Lapifuse |
| In2bones USA, LLC | $144.09 | 2021 | |
| Restor3d, INC. | $126.39 | 2025 | |
| Crossroads Extremity Systems, LLC | $98.58 | 2019 | |
| Exactech, INC. | $70.00 | 2019 | |
| Ortho Solutions INC | $50.46 | 2023 | |
| Surgenex LLC | $33.73 | 2025 | Renograft, Surmatrix, Pellograft |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $20.16 | 2021 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$175,000.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.